The antioxidant activity of ferulic acid on MPTP induced Parkinson's disease in mice

Asian Journal of Microbiology, Biotechnology and Environmental Sciences

Volumn 13, Issue 4, 2011, Pages 677-683

  Usha Rani, N ^a   Ananthi, T ^a  

^a STET Women's College   (India)

Author keywords

Antioxidant activity; Ferrulic acid; MPTP; Parkinson's disease

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; CATALASE; FERULIC ACID; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; LIPID PEROXIDATION; MALE; MOUSE; NONHUMAN; PARKINSON DISEASE;

ANIMALIA; MUS;

EID: 84855716962     PISSN: 09723005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Adams, J.D. and Odunze, I.N. 1993. Biochemical mechanisms of 1-methyl 4-phenyl 1,2,3,6-tetrahydropyridine toxicity. Biochem. Pharmacol. 41: 1099-1105.
2. Ahmad, M., Saleem, S., Ahmad, A.S., et al., 2005. Neuroprotective effects of Withania somnifera on 6-hydroxydopamine induced Parkinsonism in rats. Hum. Exp. Toxicol. 24: 137-147. (Pubitemid 40605154)
3. Balasubashini, M.S., Rukkumani, R. and Menon, V.P. 2003. Protective effects of ferulic acid on hyperlipidemic diabetic rats. Acta Diabetol. 40: 118-122. (Pubitemid 37288120)
4. Beauchamp, C. and Fridovich, I. 1971. Superoxide dismutase: Improved assays and an assay applicable to acrylamide gels. Anals of Biochemistry. 44: 276-87.
5. Bernheimer, H., Birkmayer, W., Hornykiewicz, O., et al., 1973. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci. 20: 415-55.
6. Cassarino, D.S., Fall, C.P., Swerdlow, R.H., et al., 1997. Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease. Biochem. Biophys. Acta. 1362: 77-86. (Pubitemid 28027114)
7. Cheesemann, K.L. and Slater, T.F.1993. An introduction to free radical biochemistry. Br. Med. Bull. 9: 481-483.
8. Chen, X, Zhou, Y, Chen, Y, Zhu, Y, Fang, F. and Chen, L. 2005. Ginsenoside Rg1 reduces MPTP induced substantia nigra neuron loss by suppressing oxidative stress. Acta Pharmacol. Sin. 26: 56-62. (Pubitemid 40093241)
9. Chieuh, N., Fu, Y. and Porres, J. 1994. Selenium dependent cellular glutathione peroxidase protects mice against a pro-oxidant induced oxidation of NADPH, NADH, lipids and proteins. FASEB J. 13: 1467-1475. (Pubitemid 29382514)
10. Dexter, D.A., Chan, P. and Sandy, M.S. 1989. Glutathione in Parkinson's disease: a link between oxidative stress and mitochondrial damage? Ann Neurol. 32: S111-5.
11. Esterbauer, H., Schaur, R.J. and Zollner, H. 1991. Chemistry and biochemistry of 4-hydroxy nonenol, MDA and related aldehydes. Free Rad. Biol. Med. 11: 81-128. (Pubitemid 121003917)
12. Forno, L.S., De Lanney, L.E., Irwin, I. and Langston, J.W. 1993. Similarities and differences between MPTP-induced parkinsonsim and Parkinson's disease. Neuropathologic considerations. Adv. Neurol. 60: 600-608.
13. Genc, S., Akhisaroglu, M., Kuralay, F. and Genc, K. 2002. Erythropoietin restores glutathione peroxidase activity in 1-methyl-4-phenyl-1,2,5,6- tetrahydropyridine-induced neurotoxicity in C57BL mice and stimulates murine astroglial glutathione peroxidase production in vitro. Neurosci. Lett. 321: 73-76. (Pubitemid 34185502)
14. Glowinski, J. and Iversen, L.L. 1996. Regional studies of cateholamines in the rat brain-I. J. Neurochem. 13: 655-669.
15. Halliwell, B. and Gutteridge, J.M. 1985. Free radicals in Biology and Medicine. Oxford University Press, Newyork. pp.177-192.
16. Javitch, V., Jokowec, M., Burke, R.E. and Przedborski, S. 1985. Time course & morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl 4-phenyl 1,2,3,6 tetrahydropyridine. Neurodegeneration. 4: 257-269.
17. Jollow, D.J., Mitchell, J.R., Zampagloine, N. and Gillete, J.R. 1974. Bromobenzene-induced liver necrosis: protective role of glutathione and evidence for 3,4 bromobenzeneoxide as the hepatotoxic intermediate. Pharmacology. 11: 151-69.
18. Kanski, J., Aksenova, M. and Stoyanova, A. 2002. Butter field D.A. Ferulic acid antioxidant protection against hydroxyl and peroxyl radical oxidation in synaptosomal and neuronal cell culture systems in vitro: structure activity studies. J. Nutr. Biochem. 13: 273-281. (Pubitemid 34556688)
19. Kirkman, H.N. and Gaetani, G.F. 1984. Catalase. A tetrameric enzyme with four tightly molecules of NADPH. Proc. Natr. Acad. Sci. 81: 4343-4347. (Pubitemid 14052441)
20. Langston, J.W., Ballard, P., Tetrud, J.W., et al., 1983. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science. 219: 979-980. (Pubitemid 13189531)
21. Lowry, O.H., Rosebrough, N.J., Farr, A.L. and Randall, R.J. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem. 193: 265-275.
22. Mates, J.M. and Gomez, C.P. 1999. Antioxidant enzymes and human diseases. Clin. Biochem. 32: 595-603. (Pubitemid 30039087)
23. Mohandas, J., Marshall, J.J. and Duggin, G.G. 1984. Differential distribution of glutathione and glutathione related enzymes in rabbit kidneys: Possible implication in analgesic neuropathy. Cancer Research. 44: 5086-5091.
24. Munoz, A., Rey, P., Guerra, M.J. 2006. Reduction of dopaminergic degeneration and oxidative stress by inhibition of angiotensin converting enzyme in a MPTP model of Parkinsonism. Neuropharmacol. 51: 112-120.
25. Prasad, K.N., Cole, W.C. and Kumar, B.1999. Multiple antioxidants in the prevention and treatment of Parkinson's disease. Journal of the American College of Nutrition. 18: 413-423. (Pubitemid 29455713)
26. RajaSankar, S., Manivasagam, T. and Surendran, S. 2009b. Withania somnifera root extract improves catecholamines and physiological abnormalities seen in a Parkinson's disease model mouse. Journal of Ethnopharmacology. 125: 369-373.
27. Rajeswari, A. 2006. Curcumin protects mouse brain from oxidative stress caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Eur. Rev. Med. Pharmacol. Sci. 10: 157-161. (Pubitemid 44468939)
28. Rojas, P. and Rios, C. 1993. Increased striatal lipid peroxidation after intercerbroventricular MPP+ administration to mice. Pharmacol. Toxicol. 72: 364-368. (Pubitemid 23188501)
29. Ruan, H., Yang, Y. and Zhu, X. 2009. Neuroprotective effects of (+/- catechin against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) - induced dopaminergic neurotoxicity in mice. Neurosci Lett. 450: 152-157.
30. Shashikant, Nikam, Padmaja Nikam, S.K. Ahaley and Ajit, V. Sontakke 2009. Oxidative stress in Parkinson's disease. Indian Journal of Clinical Biochemistry. 24: 98-101.
31. Thomas, H., Bjorklund, M. and Riekkinen, Jr. P. 2000. Cognitive changes in mice following moderate MPTP exposure. Brain Res. Bull. 45: 577-582.
32. Thiffault, C., Anumount, N., Quirion, R. and Poirer, J. 1995. Effect of MPTP and L-deprenyl on antioxidant enxymes and lipid peroxidation leves in mouse brain. J. Neurochem. 65: 2725-2733. (Pubitemid 3002930)
33. Tipton, K.F. and Singer, T.P. 1993. Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds. J. Neurochem. 61: 1191-1206. (Pubitemid 23285075)
34. Yadav, P., Sarkar, S. and Bhatnagar, D. 1997. Lipid peroxidation and antioxidant enzymes erythrocytes and tissues in aged diabetic rats. Indian J. Exp. Biol. 35: 389-392. (Pubitemid 128489754)